activesellsec_filings

AAP 10-Q report for 2025-04-19

Advance Auto Parts (AAP) filed its Form 10-Q for the quarterly period ended April 19, 2025. The filing includes condensed consolidated financial statements, notes, management’s discussion and analysis (MD&A) table of contents, and disclosures on restructuring, segment reporting, risk factors, and controls. Key interim metrics reported include $2,583M net sales for the 16-week period, $24M net income, $1,672M cash and cash equivalents, and 4,285 stores as of April 19, 2025.

Confidence
60 / 100
Assets
1
Authors
1
Outcome
open

Linked assets

AAP — Advance Auto Parts, Inc. — NYSE: AAP. The filing reports interim financials and disclosures relevant to liquidity, restructuring, and capital structure; no new securities or exchange listings were announced in the filing.

AAPsellmixed

Advance Auto Parts (AAP) Form 10-Q for quarter ended April 19, 2025: condensed interim financial statements and disclosures. Reported 16-week net sales $2,583M, net income $24M, cash and cash equivalents $1,672M, inventories $3,731M, total assets $10,617M, total liabilities $8,420M, shares outstanding ~59.9M.

Confidence: 60 / 100Start: $49.17Latest: $48.12Return: 2.14%

This play summarizes AAP’s Form 10-Q for the period ended April 19, 2025. The filing includes the cover page, table of contents, condensed consolidated balance sheet, statements of operations, cash flows, changes in equity, selected notes and disclosures on restructuring, segment reporting and risk factors. The excerpt provides interim financials (including restructuring charges of $118M in the period) and operating metrics (4,285 stores, 881 Carquest stores served) but does not add events beyond the reported interim results. Use the filing to update liquidity, restructuring and capital-structure assessments; the recommended strategy is sell.

Source proof

Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review

This play is based on Advance Auto Parts, Inc.’s Form 10-Q filed for the quarter ended April 19, 2025. The filing provides the SEC cover page, table of contents, condensed consolidated balance sheet, statements of operations, statements of cash flows, statements of changes in stockholders’ equity, selected notes, and related disclosures (including forward‑looking statements and risk-factor updates).

SNBR 10-Q report for 2026-04-04
Sleep Number Corp · May 12, 2026, 3:06 AM EDT

This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

View source
SOUN 10-Q report for 2026-03-31
SOUNDHOUND AI, INC. · May 11, 2026, 5:28 PM EDT

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

View source
WEAT 10-Q report for 2026-03-31
Teucrium Commodity Trust · May 11, 2026, 5:19 PM EDT

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

View source
ACHR 10-Q report for 2026-03-31
Archer Aviation Inc. · May 11, 2026, 5:01 PM EDT

The provided excerpt is only the cover/header portion of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

View source
CLSK 10-Q report for 2026-03-31
CLEANSPARK, INC. · May 11, 2026, 4:58 PM EDT

This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.

View source
ASTS 10-Q report for 2026-03-31
AST SpaceMobile, Inc. · May 11, 2026, 4:40 PM EDT

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

View source
SMCI 10-Q report for 2026-03-31
Super Micro Computer, Inc. · May 11, 2026, 4:38 PM EDT

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

View source
ABCL 10-Q report for 2026-03-31
AbCellera Biologics Inc. · May 11, 2026, 4:18 PM EDT

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.

View source

Supporting authors

Research bundle includes one author/contributor and references to the primary SEC filing for source data. No independent analyst forecasts are included; all numeric values are drawn from the company’s disclosed interim financial statements.

Unlock full thesis monitoring

Action: sell (recommended strategy). Use the filing to update liquidity and restructuring assumptions, monitor restructuring costs and operating income trajectory, and reassess valuation and capital-allocation expectations for AAP.